How HIV's Nef protein makes the virus more infectious even without SERINC

Basis of Serinc-Independent Enhancement of Infectivity by HIV-1Nef

NIH-funded research Veterans Medical Research Fdn/san Diego · NIH-11253295

Researchers are searching for the missing protein or pathway that lets the HIV protein Nef boost virus infectivity, with the goal of helping people living with HIV.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVeterans Medical Research Fdn/san Diego NIH-funded
Lab location1 site (San Diego, United States)
Project IDNIH-11253295 on NIH RePORTER

What this research studies

This lab project looks at how the HIV protein Nef increases the ability of the virus to infect cells even when known inhibitors like SERINC proteins are not responsible. The team will use proximity-proteomics and other molecular tools in T cell lines and likely primary CD4+ T cells to find proteins or pathways that interact with Nef. The work is open-ended and exploratory, aiming to identify previously unknown factors that explain Nef's effect on viral infectivity. Because this is bench research, the project may request blood or immune-cell samples from donors rather than running a clinical treatment trial.

Who could benefit from this research

Good fit: Ideal candidates would be adults living with HIV who are willing to donate blood or immune cells for laboratory research, typically near San Diego.

Not a fit: People without HIV or those not able or willing to provide samples are unlikely to receive direct benefit from this laboratory-focused project.

Why it matters

Potential benefit: If successful, the project could uncover new drug targets to block Nef-driven increases in HIV infectivity and inform future therapies.

How similar studies have performed: Similar proteomics approaches have previously identified factors like SERINC5 and other Nef partners, but the SERINC-independent mechanism this project targets remains novel and unresolved.

Where this research is happening

San Diego, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.